SCCF is not a hospital or clinic. For diagnosis or treatment, consult a qualified healthcare professional.

Tislelizumab in Esophageal and Gastric Cancer Management

Dr. Medical Panel
General / Multiple Treatment Options

Key Takeaways

  • New immunotherapy option for GI cancers
  • Potential in esophageal and gastric cancer
  • Clinical trial data supports use
  • Combination approaches being studied

Who is this video for?

PatientsCaregivers

Questions to ask your doctor

  • Is immunotherapy an option for my cancer?
  • What combinations are being used?

Have questions about this topic?

Suchi can summarize key points and help you prepare questions for your doctor.

Ask Suchi about this video